搜尋結果
Doctor's recommendation does not bar patient's lawsuit over device -California top court
Reuters· 5 小時前U.S. District Judge R. Gary Klausner in Los Angeles had ruled against plaintiff Michelle ...
Argenx’s Vyvgart Shot Gains US Approval for Rare Nerve Disorder
Bloomberg· 6 小時前Argenx SE’s Vyvgart Hytrulo shot gained US approval to treat a rare nervous system disorder, a ...
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters· 7 小時前, opens new tab on Friday said its popular weight-loss drug Zepbound helped resolve moderate to ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 7 小時前Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the ...
US FDA approves Bristol Myers' colorectal cancer therapy
Reuters· 8 小時前The approval under the agency's accelerated process was based on an early- to mid-stage ...
Painful deja vu as Slovakia punished by Ukraine
Reuters· 11 小時前Slovakia coach Francesco Calzona said there had been no celebrating after his side’s shock ...
Khosla-backed Marble, built by former Headway founders, offers affordable group therapy for teens
TechCrunch· 12 小時前A recent report from the Center of Disease Control found that nearly one in three girls have ...
Sarepta's Stock Soars on Best-Case FDA Decision for its Muscular Dystrophy Treatment
The Wall Street Journal· 12 小時前For biotech companies, regulatory approval is usually one of many steps needed to convince Wall ...
The termination of patent terminal disclaimers?
Reuters· 13 小時前The United States Patent and Trademark Office (USPTO) is proposing a rule change, that if ...
Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
CNBC· 14 小時前The decline comes after the AI chipmaker on Tuesday briefly topped Microsoft as the most ...